Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
SHSE:688298's 9-Day RSI is ranked better than 73.58% of 863
companies
in the Medical Devices & Instruments industry
Industry Median: 48.52
vs SHSE:688298: 64.26
Zhejiang Orient Gene Biotech Co (SHSE:688298) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Zhejiang Orient Gene Biotech Co 9-Day RSI Related Terms
SHSE:688298 vs ABT, SYK, MDT: 9-Day RSI Comparison
For the Medical Devices subindustry, Zhejiang Orient Gene Biotech Co's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Orient Gene Biotech Co 9-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zhejiang Orient Gene Biotech Co's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Zhejiang Orient Gene Biotech Co's 9-Day RSI falls into.
Zhejiang Orient Gene Biotech Co (SHSE:688298) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Orient Gene Biotech Co (SHSE:688298) has a 9-Day RSI of 64.26 as of Aug. 20, 2026. According to the industry distribution chart, Zhejiang Orient Gene Biotech Co ranks #228 out of 863 companies in the Medical Devices & Instruments industry, placing it in the top 26.4%.
Is Zhejiang Orient Gene Biotech Co's 9-Day RSI too high?
Zhejiang Orient Gene Biotech Co's current 9-Day RSI is 64.26. The Medical Devices & Instruments industry median 9-Day RSI is 48.52. Zhejiang Orient Gene Biotech Co's value of 64.26 is 32.4% above this industry median. Based on the distribution chart, Zhejiang Orient Gene Biotech Co ranks #228 out of 863 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Zhejiang Orient Gene Biotech Co has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Orient Gene Biotech Co's 9-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zhejiang Orient Gene Biotech Co ranks #228 out of 863 companies for 9-Day RSI. This puts Zhejiang Orient Gene Biotech Co in the upper half of its industry. The industry median 9-Day RSI is 48.52. Zhejiang Orient Gene Biotech Co's value of 64.26 is 32.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Devices & Instruments company?
The median 9-Day RSI among Medical Devices & Instruments companies is 48.52, based on 863 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Orient Gene Biotech Co's current 9-Day RSI of 64.26 is 32.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 9-Day RSI is 48.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Orient Gene Biotech Co's current 9-Day RSI is 64.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Orient Gene Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Orient Gene Biotech Co (SHSE:688298) is currently considered Possible Value Trap. The stock's GF Value™ is ¥30.43, compared to a current price of ¥19.85 — trading 34.8% below its estimated fair value. The current 9-Day RSI is 64.26 and 32.4% above the Medical Devices & Instruments industry median of 48.52. Zhejiang Orient Gene Biotech Co's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Zhejiang Orient Gene Biotech Co (SHSE:688298), the current 9-Day RSI is 64.26 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Orient Gene Biotech Co (SHSE:688298) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Orient Gene Biotech Co stock appears to be undervalued.
The current stock price of ¥19.85 is trading 34.8% below its estimated GF Value™ of ¥30.43.
GuruFocus considers Zhejiang Orient Gene Biotech Co to be Possible Value Trap.
Key valuation signals for SHSE:688298:
9-Day RSI: 64.26
GF Value™: ¥30.43 vs. price of ¥19.85 (34.8% below fair value)
Industry Position: 32.4% above the Medical Devices & Instruments median (#228 of 863)
No single metric tells the full story. See the SHSE:688298 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Orient Gene Biotech Co Ltd is engaged in production, research, development and sale of vitro diagnostic products. The company's products include Genetic diagnosis, Colloidal gold rapid diagnostic tests, Dry chemical strips (urinalysis), Bio-liquid diagnostic kits, Clinical test instruments, POCT time-resolved Fluor immunoassay Test kit (TRFI), and Raw materials.
63GF Score
Get the complete analysis for SHSE:688298
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688298 has been successfully added to your 
